Greenwich LifeSciences, Inc.GLSINASDAQ
LOADING
|||
EPS Growth Trend
Above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
0.00%
↑ 100% above average
Average (27q)
-88.01%
Historical baseline
Range
High:90.46%
Low:-1674.19%
Volatility
-2005.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | -20.00% |
| Q1 2025 | 59.02% |
| Q4 2024 | -205.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | -5.26% |
| Q1 2024 | 9.52% |
| Q4 2023 | -10.53% |
| Q3 2023 | -46.15% |
| Q2 2023 | 18.75% |
| Q1 2023 | 23.81% |
| Q4 2022 | -16.67% |
| Q3 2022 | -223.74% |
| Q2 2022 | 62.93% |
| Q1 2022 | 16.67% |
| Q4 2021 | -170.27% |
| Q3 2021 | -14.63% |
| Q2 2021 | -24.68% |
| Q1 2021 | 64.15% |
| Q4 2020 | -504.65% |
| Q3 2020 | -22.16% |
| Q2 2020 | 13.73% |
| Q1 2020 | 27.40% |
| Q4 2019 | 0.00% |
| Q3 2019 | 87.23% |
| Q2 2019 | -1674.19% |
| Q1 2019 | 90.46% |
| Q4 2018 | 0.00% |